000046653 000__ 02128nam\a2200445\i\4500
000046653 001__ 46653
000046653 003__ SzGeWIPO
000046653 005__ 20240705171534.0
000046653 006__ m\\\\e\\\d\\\\\\\\
000046653 008__ 221017s2022\\\\sz\\\\\\\\\\\\000\0\eng\d
000046653 0247_ $$a10.34667/tind.46653$$2doi
000046653 035__ $$aWIPO/PUB/ECONSTAT/WP/68/EN
000046653 035__ $$a(OCoLC)1348116451
000046653 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000046653 041__ $$aeng
000046653 043__ $$aa-cc---
000046653 24500 $$aCalculating Private and Social Returns to COVID-19 Vaccine Innovation.
000046653 264_1 $$aGeneva, Switzerland :$$bWorld Intellectual Property Organization,$$c2022.
000046653 300__ $$a19 pages ;$$c[28] cm.
000046653 336__ $$atext$$btxt$$2rdacontent
000046653 337__ $$aunmediated$$bn$$2rdamedia
000046653 338__ $$avolume$$bnc$$2rdacarrier
000046653 4901_ $$aEconomics Working Papers,$$x2957-8256 ;$$vno. 68
000046653 516__ $$aOnline publication
000046653 520__ $$aWhat is the return to COVID-19 vaccine innovation? This paper seeks to quantify both private and social returns, using available data on commercialized vaccines and certain assumptions about the pandemic’s epidemiological path as well as the economic costs of containment measures. The calculations reveal high returns to innovation. In the baseline scenario, the social benefit of vaccine innovation amounts to 70.5 trillion United States (U.S.) dollars globally, exceeding its private benefit by a factor of 887. The calculations bear on the private and public incentives to invest in vaccine innovation.
000046653 542__ $$fCC BY 4.0 WIPO
000046653 650_4 $$aCOVID-19 pandemic
000046653 650_0 $$aVaccines.
000046653 650_0 $$aMedical innovations.
000046653 7001_ $$aFink, Carsten,$$eauthor
000046653 830_0 $$aEconomics Working Papers ;$$vno. 68.
000046653 8564_ $$w761ce76e-8c58-40e1-a615-08f255b0c6e8$$s1360802$$fwipo-pub-econstat-wp-68-en-calculating-private-and-social-returns-to-covid-19-vaccine-innovation.pdf$$fwipo-pub-econstat-wp-68-en-calculating-private-and-social-returns-to-covid-19-vaccine-innovation.pdf$$uhttps://tind.wipo.int/record/46653/files/wipo-pub-econstat-wp-68-en-calculating-private-and-social-returns-to-covid-19-vaccine-innovation.pdf
000046653 85648 $$3Abstract with links to full text$$uhttps://dx.doi.org/10.34667/tind.46653
000046653 901__ $$aWIPO/PUB/ECONSTAT/WP/68
000046653 902__ $$a46653_en
000046653 903__ $$aEconomics working papers
000046653 904__ $$aWorking paper
000046653 909__ $$ooai:tind.wipo.int:46653$$pWIPOPUB
000046653 909__ $$ooai:tind.wipo.int:46653$$pWIPOPUB
000046653 909CO $$ooai:tind.wipo.int:46653$$pWIPOPUB
000046653 980__ $$aWIPOPUB$$aERWP